Memorial Sloan-Kettering Cancer Center
1275 York Avenue
New York, NY 10065
Doctors Affiliated with this Treatment Facility
Founded in 1884, Memorial Sloan-Kettering Cancer Center (MSKCC) is the world’s oldest and largest private cancer center – and one of the best. The hospital rated as the No. 2 cancer hospital in the country in 2010, according to U.S. News & World Reports, and continues to be a leader in cancer surgery, chemotherapy and radiotherapy. Memorial Sloan-Kettering has its main campus in New York City on the island of Manhattan, although the center also has other, smaller locations in New Jersey, Long Island and Westchester County, New York.
Memorial Sloan-Kettering Cancer Center is the result of a merger between two highly respected institutions: Memorial Hospital, which provides patient care, and the Sloan-Kettering Institute, the research arm of the hospital.
The institution traces its roots back to 1884, when a hospital known as the New York Cancer Hospital was constructed. Originally located on Manhattan’s Upper West Side, the hospital was relocated to York Avenue in 1936 after the prominent philanthropist John D. Rockefeller, Jr. donated land for a new building. Among the funders of the new hospital were the business magnate John J. Astor and his wife, Charlotte. In the early 1970s, the hospital was rebuilt on the same site and was renamed Memorial Hospital.
Meanwhile, the Sloan-Kettering Institute was founded in the 1940s by two executives of General Motors, Alfred P. Sloan and Charles F. Kettering. The institute was funded by a $4 million gift from Sloan and $3 million in other donations; again, the Rockefeller family offered its support. The result was an impressive, 13-story biomedical research facility built adjacent to Memorial Hospital. Memorial Hospital and the Sloan-Kettering Institute were unified in 1960 and became known, as it is today, as Memorial Sloan-Kettering Cancer Center.
Memorial Sloan-Kettering Cancer Center has recently expanded with new construction, and has introduced a network of state-of the-art outpatient cancer treatment facilities in Long Island, Westchester County and New Jersey. The center employs 11,000 people and accommodated more than 500,000 outpatient visits in 2010. The hospital is affiliated with several medical school programs, including the Weill Cornell Medical School, the Tri-Institutional MD/PhD program and the Tri-Institutional Training Program in Chemical Biology. In 2006, Memorial-Sloan Kettering was one of six institutes to receive a $20 million grant from American billionaire Daniel K. Ludwig for cancer research; the money is being used for immunology research.
Mesothelioma Treatment at Memorial Sloan-Kettering Cancer Institute
Just 2,000 to 3,000 cases of mesothelioma are diagnosed in the United States each year, making the disease 100 times less common than regular lung cancer. The disease typically presents with symptoms such as shortness of breath and pleural effusion (fluid in the lungs); however, those symptoms mirror those of other diseases, so it’s sometimes difficult to get a proper diagnosis – especially with doctors who are not familiar with the disease.
The team of mesothelioma doctors at Memorial Sloan-Kettering determine a course of treatment that is best suited for the individual, depending on lung function, how advanced the cancer is, and the patient’s overall health. A CAT scan or PET scan is generally used in the detection of the disease. If it is determined to be mesothelioma, treatment often involves a combination of surgery, chemotherapy and radiation. However, different types of mesothelioma respond differently to various types of chemotherapy, so it is important that treatment be tailored to the individual.
Patients with less advanced pleural mesothelioma may be recommended for surgery; this could include removing the infected lining of the lung or the entire lung, depending on the severity of the cancer. (For most pleural mesothelioma patients, the cancer is present only in one lung at the time of diagnosis.) Those patients who have more advanced mesothelioma may not be able to tolerate surgery and are usually treated with chemotherapy alone. Recent studies have shown that a combination of two chemotherapy drugs, Alimta and cisplatin, can increase survival and improve quality of life for mesothelioma patients.
Other treatment options may be available to some individuals. Memorial Sloan-Kettering is always researching cutting-edge treatments and therapies for mesothelioma, and participation in a clinical trial may be offered to some patients.
In this video, Memorial Sloan-Kettering Cancer Center thoracic oncologist and mesothelioma program director Dr. Lee Krug, discusses new guidelines for diagnosing and treating mesothelioma. Dr. Krug reviews the updated protocols for making an accurate mesothlioma diagnosis as well as the recommended modalities of therapy depending on the stage and type of mesothelioma being treated as well as important clinical trials currently underway.
Memorial Sloan-Kettering Cancer Center – History
Wikipedia – Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center – Mesothelioma